Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

743

Adjuvant chemotherapy for resected biliary tract cancers: A fluorouracil-based scheme beats out a gemcitabine-based

Ya-Fei Hu1,2, Wen-Jie Ma1,2, Yan-Wen Jin1,2

  • 1Department of Biliary Surgery, West China Hospital, Sichuan University, Chengdu, China.

Hepatology (Baltimore, Md.)
|October 23, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

266
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

483

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

743
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

266
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

483

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

Articles linked to this work by shared authors, journal, and citation graph.

Translational and Implementation Barrier in the Management of Biliary Tract Cancer: Diagnostic, Molecular, Therapeutic, and Patient-Centered Challenges.

Journal of gastroenterology and hepatology·2026

Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers.

Journal of gastroenterology and hepatology·2026

Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma.

Cancer medicine·2025

Analysis on clinicopathological characteristics and prognostic factors of adenoma-associated gallbladder carcinoma.

Updates in surgery·2025

Individualized Prognostic Insights: CONUT-GBRS for Survival Prediction in Gallbladder Cancer.

Cancer medicine·2025

Preoperative biliary drainage for patients with malignant obstructive jaundice: an update on the systematic review and model-based Bayesian network meta-analysis.

International journal of surgery (London, England)·2025

Saroglitazar improves hepatic steatosis and liver enzymes in women with polycystic ovary syndrome and MASLD: A multicenter, double-blind, placebo-controlled study.

Hepatology (Baltimore, Md.)·2026

Upholding telomeres prevents hepatic stellate cell transdifferentiation and liver fibrogenesis.

Hepatology (Baltimore, Md.)·2026

Autoimmune hepatitis and primary biliary cholangitis are among a subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway.

Hepatology (Baltimore, Md.)·2026

Adjuvant pegylated interferon-alpha after nucleos(t)ide analog withdrawal drives a temporally coordinated expansion of regulatory B cells and contraction of HBV-specific T cells.

Hepatology (Baltimore, Md.)·2026

An international multicenter analysis of the outcome of pediatric first variceal hemorrhage.

Hepatology (Baltimore, Md.)·2026

AASLD EXPO: Liver biopsy.

Hepatology (Baltimore, Md.)·2026

Integrated models of palliative medicine and pain management for the treatment of cancer-related pain: a review.

Current opinion in supportive and palliative care·2026

BRCAness-Driven Prognostic Model and Regimen-Specific Therapeutic Implications in Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.

International journal of cancer·2026

The allogeneic eDN70(-) CAR-T Cells Without TCR or MHC Editing Exhibit Enhanced Persistence and Function.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Presumed oxaliplatin-related Guillain-Barré syndrome: A case report and review of chemotherapy-related Guillain-Barré syndrome.

Medicine·2026

Retrospective observational study of transcatheter arterial chemoembolization (TACE) combined with PD-1 inhibitor and tyrosine kinase inhibitor (TKI) in advanced hepatocellular carcinoma.

Medicine·2026

Influenza A (H1N1) virus infection complicated by checkpoint inhibitor pneumonitis: A case report.

Medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us